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Abstract
Purpose of the study: to examine the costs and cost-effectiveness of ‘second-generation’ telecare, in addition to standard
support and care that could include ‘ﬁrst-generation’ forms of telecare, compared with standard support and care that could
include ‘ﬁrst-generation’ forms of telecare.
Design and methods: a pragmatic cluster-randomised controlled trial with nested economic evaluation. A total of 2,600
people with social care needs participated in a trial of community-based telecare in three English local authority areas. In the
Whole Systems Demonstrator Telecare Questionnaire Study, 550 participants were randomised to intervention and 639 to
control. Participants who were offered the telecare intervention received a package of equipment and monitoring services
for 12 months, additional to their standard health and social care services. The control group received usual health and
social care.
Primary outcome measure: incremental cost per quality-adjusted life year (QALY) gained. The analyses took a health and
social care perspective.
Results: cost per additional QALY was £297,000. Cost-effectiveness acceptability curves indicated that the probability of cost-
effectiveness at a willingness-to-pay of £30,000 per QALY gained was only 16%. Sensitivity analyses combining variations in
equipment price and support cost parameters yielded a cost-effectiveness ratio of £161,000 per QALY.
Implications: while QALY gain in the intervention group was similar to that for controls, social and health services costs
were higher. Second-generation telecare did not appear to be a cost-effective addition to usual care, assuming a commonly
accepted willingness to pay for QALYs.
Trial registration number: ISRCTN 43002091.
Keywords: telecare, economic evaluation, social care, older people
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Introduction
In the face of macroeconomic difﬁculties, budgetary pres-
sures [1] and rapid demographic change, [2] government and
non-governmental bodies are searching for more cost-
effective ways of supporting independent living. ‘Telecare’, a
remote and passive monitoring technology intended to allow
users to live safely and independently [3],may play an import-
ant role in this effort. Telecare has been advocated as a
means to generate cost savings, and maintain or improve the
quality of service for people with social care needs [4].
However, evidence on the impact of assistive technologies to
support independent living, such as ‘telecare’ and telehealth,
is sparse; data are especially limited on cost-effectiveness.
We examined whether ‘second-generation’ telecare [5] in
addition to standard support and care that could include
‘ﬁrst-generation’ forms of telecare is cost-effective compared
with standard support and care that could include ‘ﬁrst-
generation’ forms of telecare, under the Whole Systems
Demonstrator (WSD) programme [6].
Design and methods
The study design was a pragmatic cluster-randomised con-
trolled trial, examining the effectiveness of telecare for indivi-
duals with social care needs, and also their carers [7], when
delivered in the context of routine health and social care
practice [8]. Telecare was introduced in three English local
authorities (sites), covering four Primary Care Trusts chosen
as exemplifying on-going engagement in ‘whole-systems
redesign’ (Supplementary data are available in Age and Ageing
online ﬁle 1).
Intervention participants received a second-generation
telecare package in addition to their existing social and
healthcare services (which could include ‘ﬁrst-generation’
forms of telecare); control group participants continued to
receive their existing social care and health services (which
could include ‘ﬁrst-generation’ forms of telecare) for
12 months, after which they were offered telecare, subject to
reassessment.
Individuals eligible for the trial were invited to participate in
a nested questionnaire study; those who agreed were contacted
by interviewers who, after obtaining written consent, adminis-
tered instruments to measure outcomes [7] and collect infor-
mation needed to calculate care costs. Individuals assessed as
having cognitive impairment preventing them from completing
outcome measures on their own were ineligible for the ques-
tionnaire study, while remaining eligible for the parent trial [9].
Service use data were collected using the Client Services
Receipt Inventory [10], administered by interview at baseline
and by self-completion postal questionnaire at 4- and
12-month follow-up. Participants were asked to report service
use in the 3 months prior to each assessment. At 12-month
follow-up, participants not returning questionnaires were con-
tacted to arrange an interview (52% of questionnaires returned
were completed by interview). We focus here on costs and
outcomes collected for the questionnaire study at 12-month
compared with baseline (Supplementary data are available in
Age and Ageing online ﬁle 2 for 4-month follow-up statistics).
Telecare intervention and equipment
Telecare was deﬁned in the trial as the ‘remote, automatic
and passive monitoring of changes in an individual’s condi-
tion or lifestyle (including emergencies) in order to manage
the risks of independent living’ [7]. Telecare equipment used
in the trial can be mapped to four broad functions: monitor-
ing functional status (e.g. pendant, chair occupancy sensors),
home security (bogus caller buttons, property exit sensors)
and home environment (heat sensors, ﬂood detectors), and
facilitating the telecare package through ‘stand-alone’ devices
that do not send alerts to the monitoring centre (big button
telephones, key safes) (Supplementary data are available in
Age and Ageing online ﬁle 3). Telecare users received an equip-
ment package including base unit and pendant/bracelet and
at least one of 27 types of telecare device.
While telecare in all three sites consisted of a call centre-
based monitoring service responding to alarms and sensors,
service models nonetheless varied (Supplementary data are
available in Age and Ageing online Box 3.1, ﬁle 3). The
purpose of the trial was not to evaluate speciﬁc models of
delivery or technology conﬁgurations, but to evaluate whether
second-generation ‘telecare’ in any of its conﬁgurations nested
within a broader system of care is cost-effective compared
with usual care.
Service use and costs
To calculate health and social care costs in the 3-month
periods prior to baseline and 12-month assessments, self-
reported units of service were multiplied by the relevant
unit costs. Most unit costs (in 2009–10 prices) were nationally
applicable and taken from published sources [11, 12]
(Supplementary data are available in Age and Ageing online,
Table A4.1). Costs calculated for these 3-month periods were
multiplied by 4 to estimate costs in the pre-baseline year and in
the year of the intervention period for use in the cost-
effectiveness analyses. We also calculated the cost of a package
of telecare equipment and support (Supplementary data are
available in Age and Ageing online, ﬁle 3). Analyses took a health
and social services perspective: we included costs incurred by
the National Health Service (NHS) or local authorities. Costs
disregarded any user charges; however, only those equipment
and adaptations costs falling to the NHS or local authorities
were included (excluding privately purchased equipment).
Outcomes
The primary outcome was incremental cost per
quality-adjusted life year (QALY). QALYs were constructed,
calculating utility scores from the EQ-5D, using societal
weights [13], and taking the ‘area under the curve’, with linear
interpolation between baseline and 12-month assessment
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scores. Secondary outcomes were: perceived physical and
mental health status, psychological well-being and state-trait
anxiety (Supplementary data are available in Age and Ageing
online, ﬁle 5).
Statistical analysis
We examined relationships between costs and consequences
of telecare by calculating the incremental cost-effectiveness
ratio (ICER) and net monetary beneﬁt (NMB) of the inter-
vention. The ICER represents the difference in mean costs
between intervention and control groups (ΔC) divided by the
difference in mean outcome scores (ΔE). The intervention is
seen as cost-effective if the ICER is less than some
maximum amount (λ) that the payer is willing to pay (WTP)
for a gain in outcome, a decision rule that can be expressed
as ΔC/ΔE< λ. It follows that for the intervention to be cost-
effective, λ× ΔE − ΔC > 0, or put another way, that the
NMB (given by λ× ΔE− ΔC) exceeds zero [14]. NMB
represents the pecuniary value of extra gains in outcome
associated with the intervention, for a given WTP (λ), net of
the extra cost of the intervention [14]. We explored the prob-
ability that telecare is cost-effective over a series of values of
λ, from £0 to £90,000, encompassing the range of £20,000
to £30,000 per QALY considered by National Institute for
Health and Care Excellence (NICE) for recommending use
of technologies in the NHS [15]. Results were used to plot
cost-effectiveness acceptability curves (CEACs).
We ﬁtted seemingly unrelated regression (SUR) models of
costs and outcomes by maximum likelihood estimation, using
the user-written mysureg command [16] in Stata 12 [17]. SUR
is a system of equations, allowing any correlation between the
error terms of the cost and outcome equations to be captured
in the estimation [18]. Covariates used in these analyses were
baseline costs, baseline utility [19], site, age, sex, ethnicity,
index of multiple deprivation (IMD) 2007 quintiles [20], a
one-person household indicator, a count of chronic condi-
tions [21], dependency (baseline EQ5-D self-care domain
score) and whether the participant had a ‘personal/commu-
nity alarm’ at baseline. Cluster-robust standard errors were
used in estimating regression coefﬁcients (observations were
clustered by general practice). The difference between groups
identiﬁed by the coefﬁcient on the intervention variable in
each equation was used to calculate the ICER and the NMB.
Missing data
Imputation of costs missing at the cost category level and of
outcome data at the scale level was carried out using the
MCMC multiple imputation package in SPSS v.19 (SPSS,
Inc., Chicago, IL, USA) (Supplementary data are available in
Age and Ageing online, ﬁle 6).
Results
There were 2,600 participants in the trial (1,276 randomised
to telecare and 1,324 to usual care), from 217 general prac-
tices: 1,189 participated in the questionnaire study (550
telecare and 639 usual care) [9]. Cost data were available at
baseline for 1,182 participants and at 12-month follow-up
for 757 participants (64% of the baseline sample) (381 tele-
care and 376 control, 69 and 59% of the baseline sample,
respectively). At 12-month follow-up, outcomes data were
available for 379 telecare and 384 control participants
(69 versus 60% of the baseline sample, respectively). Both
baseline and follow-up costs were available for 375 interven-
tion and 378 control participants.
Demographic characteristics did not differ signiﬁcantly
between baseline and 12-month follow-up for the sample with
12-month data within either control or intervention groups
(Supplementary data are available in Age and Ageing online,
Table A7.1). However, participants not completing the follow-
up were on average older than the baseline sample [75.9 (SD
14.0) versus 73.2 (SD 13.7) years, t= 3.239, P= 0.0013], with
baseline costs £2,137 higher than completers [£10,874 (SD
14682) versus £8,738 (SD 10,652, t= 2.9, P= 0.0004)].
Participants in the usual care group with data available had sig-
niﬁcantly higher proportions in the 65–74 group and lower
proportions in the 85+ group, lower proportions in site 2,
higher proportions in site 3 and lower costs. Those with data
available in the telecare group had higher proportions in the
65–74 group, and lower proportions in the 85+ group.
Groups were well balanced at baseline and follow-up in terms
of age, sex, mean IMD score and baseline costs, although at
both points a larger proportion of the telecare group was in
the second IMD quintile.
Service use and costs
Participants used many services in the 3 months prior to
12-month follow-up (Supplementary data are available in
Age and Ageing online, Table A4.1). Differences (unadjusted
for case mix) between groups were small for most categories.
Reported use of such social services as home care and social
work was greater in the telecare group. Control participants
had 33 (SE 3.7) daytime home care visits on average over the
period, while telecare participants had 42 (SE 4.3) (differ-
ence of 9.6 contacts, standardised difference of 12%).
Telecare participants reported more community nursing
visits (difference of 1.6 visits, standardised difference 17%).
Proportions of participants having a ‘personal/commu-
nity alarm’ (such as a community alarm or pull-cord) were
well-balanced at baseline (51% control, 52% intervention
group); however, at 12 months, the proportion reporting
use of some form of community alarm in the control group
was 64%, 26% higher in relative terms than at baseline (a
difference in baseline and follow-up proportions of 13%,
z= −4.04, P = 0.0001) (Supplementary data are available in
Age and Ageing online, ﬁle 4, Table A4.2).
Participants received between 1 and 11 items of WSD tele-
care equipment (mean 4.7; mode 4) (Supplementary data are
available in Age and Ageing online, ﬁle 3, Table A3.1). Average
annuitised equipment costs were £81 (SE 1.9) for all partici-
pants completing baseline assessments and £82 (SE2.3) for
those completing the 12-month follow-up (Table 1).
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Hospital costs constituted 25% of total health and social
care costs at the 12-month follow-up (if excluding interven-
tion costs); day care and community social care costs together
contributed 50%, and primary care costs, 13% (Table 2).
A telecare support and equipment package cost £791 per
annum, contributing 9% to overall health and social care
costs per person. Including direct intervention costs, inter-
vention group costs (unadjusted for case-mix) were greater
than control group costs (standardised difference 15%).
Cost-effectiveness
There was a small, not statistically signiﬁcant difference in
mean adjusted QALY scores at 12 months in favour of the
telecare group [0.003 (−0.018, 0.024)] (Table 2). Costs, in-
cluding intervention costs, were £1,014 (95% CI −525,
2,553) higher per annum for telecare than control partici-
pants. Cost per additional QALY was £297,000 (Table 2).
ICERs for costs excluding project management and for costs
excluding dedicated telecare responder costs were slightly
lower (£269,000 and £277,000, respectively). The probability
that a decision-maker would ﬁnd telecare cost-effective at a
willingness-to-pay of £30,000 for an additional QALY gain
was 16% (Supplementary data are available in Age and Ageing
online, Figure A8.1). The probability that telecare was cost-
effective did not reach 50% even assuming willingness-to-pay
of £90,000 per QALY. Excluding project management-
speciﬁc posts and contracts, and assuming a willingness-to-pay
of £30,000 per QALY, the probability that the intervention
was cost-effective slightly increased to 18%. Analysis excluding
the costs of dedicated response services in sites 2 and 3
yielded similar results. (see Supplement 5 for secondary
outcome results.)
Sensitivity analyses
Assuming that telecare support might be delivered at a lower
(‘mainstream’) cost of £5 per week [22], the probability of tel-
ecare being cost-effective at a WTP of £30,000 was 30%.
The ICER was £173,000 (Table 2). Input prices for equip-
ment were varied by assuming that equipment was purchased
at half the price paid within the trial: the probability of tele-
care being cost-effective changed slightly to 17%, at WTP of
£30,000 (Supplementary data are available in Age and Ageing
online, Figure A8.2). Combining equipment and support
cost scenarios, the probability that telecare was cost-effective
was 31% at a WTP of £30,000, and the ICER was £161,000.
Discussion
This large-scale, randomised controlled trial contributes to
the limited international evidence on the cost-effectiveness
of telecare.
There were some limitations. Some resource use data
were not available (e.g. numbers of alerts, types of call-centre
responses to participants); numbers of dedicated response
visits were not available at the individual level. The propor-
tion of trial participants opting into the questionnaire study
differed somewhat between groups (48.3% in telecare and
43.1% in usual care) [9], and numbers in the control group
were 16% greater than numbers in the intervention group,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1.Mean service costs and QALYa
Resource item Usual care (SE)
(n= 378)
Telecare (SE)
(n= 375)
Raw difference
(95% CI)
Standardised
difference (%)
Total hospital costs 1,861 (209.8) 2,042 (307.1) 181 (−548.5, 909.7) 3.5
Total primary care costs 926 (58.3) 1,075 (96.7) 149 (−72.2, 370.4) 9.6
Total care home respite costs 31 (20.6) 76 (44.6) 46 (−50.5, 141.8) 6.8
Total community care costs 2,850 (413.2) 3,324 (316.5) 474 (−548.7, 1,497) 6.6
Total mental healthcare costs 50 (25.3) 70 (43.7) 20 (−78.7, 119.2) 2.9
Total day care costs 757 (108.9) 787 (110.4) 30 (−274.6, 334.3) 1.4
Total adaptations costs 30 (8.3) 16 (3.4) −15 (−32.3, 3.2) −12.2
Total equipment costs 8 (1.8) 9 (2.2) 1 (−4.2, 6.9) 3.5
Total medication costs 778 (30.8) 718 (31.5) −60 (−146.5, 26.4) −9.8
Total costs excluding telecare delivery and equipment 7,290 (531.6) 8,117 (558.5) 826 (−687.1, 2,339.7) 7.8
Telecare equipment costs 4 (1) 82 (2.3) 78 (73, 82.9)* 149.4
Telecare intervention costs 35 (8.6) 710 (15.2) 676 (641.3, 709.9)* 163.0
Total costs including telecare delivery and equipment 7,329 (532.2) 8,909 (559.9) 1,580 (63.6, 3,096)** 14.9
Less project management posts and contracts 7,324 (532) 8,806 (559.6) 1,482 (2, 3,019.7) 13.9
Less dedicated responder costs 7,324 (532) 8,837 (560) 1,513 (32.9, 3,051) 14.2
Sensitivity
At 50% reduction in equipment prices 7,298 (528.3) 8,862 (558.4) 1,564 (55.3, 3,072.4)* 14.7
£5 cost per week 7,306 (531.6) 8,450 (558) 1,144 (−332.5, 2,679.8) 10.8
£5 cost per week + 50% reduction in equipment prices 7,304 (531.6) 8,408 (558) 1,104 (−371.4, 2,640.7) 10.4
QALY 0.333 (0.016) 0.321(0.016) −0.012 (−0.057, 0.034) −3.7
aAnnual equivalent costs for 753 cases with baseline cost data available.
*P< 0.01 on the t-test.
**P< 0.05 on the t-test.
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raising the possibility of post-randomisation self-selection, a
particular threat to cluster-randomised trials; 40% of the
control group, and 32% of the intervention group were lost
to the 12-month follow-up; these differential attrition rates
could have led to a bias in favour of the intervention group.
However, baseline characteristics did not differ substantially
between available cases at baseline and follow-up within
groups. Analyses adjusted for confounders that may have
inﬂuenced drop-out, and so compensated to some extent for
imbalances at follow-up. It remains possible that characteris-
tics not assessed may have created between-group differences
at baseline or follow-up, or between completers and
non-completers.
Practices of assessing need for telecare were not standar-
dised, with implications for external validity. Telecare services
outside the sites may not assess need for telecare in the same
way as inside the sites. The very large size of the trial popula-
tion meant that it would have been impractical to collect and
analyse detailed (and largely qualitative) information on varia-
tions in assessment practices; by the same token it is likely
that within the trial there was a range of assessment models,
some of which will have existed outside the sites as well.
Drop-out from the trial into care homes or because of
death prior to 12-month follow-up was not considered within
these analyses. Costs of health and social care services over the
period of the study were estimated by multiplying costs for the
3-month period prior to the 12-month follow-up by four, as-
suming that across all categories of service use, costs were
relatively constant over the year. Other WSD-funded research
draws on longitudinal administrative data to examine 12-month
mortality, entry into long-term residential or nursing care and
costs of a more restricted range of health and social services
for trial participants [21]. Mortality rates in that study were
similar in both groups (8.9% usual care versus 8.7% telecare),
as were rates of permanent admission to care homes (3.2%
usual care versus 3.1% telecare).
The assumed impacts of telecare systems require further
consideration. To deﬁne the impact of telecare in general
poses a challenge when the design of systems to support tele-
care is variable and the technology itself is evolving. The
scope of the technology in this evaluation encompassed
remote, automatic and passive monitoring systems that go
beyond older and more basic forms of telecare focused on
summoning assistance (which could form part of standard
support and care). The reassurance provided by telecare
systems has been said to improve quality of life for users
[9, 23, 24]. We chose to use the EQ-5D as it is a generic
measure of health-related quality of life that is useful as a
basis for comparing alternative technologies [15] and is suit-
able for use with older populations (cf. [25, 26]). The dimen-
sions of health covered by EQ-5D (self-care, anxiety/
depression, usual activities, pain/discomfort, mobility) are
relevant to the expected beneﬁts of telecare. However, while
the instrument is sensitive to change in situations where
changes in health are expected to be substantial [25], this may
not be the case with telecare. EQ-5D may not be able to
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Differences in cost and effect between telecare and usual care groups (12 months)a, annual equivalent
Values in means (95% CI) unless
otherwise stated
Outcomes/total costs
(usual care = 378)
Outcomes/total costs
(telecare = 375)
Difference in outcomes/total costs/ICER
(usual care = 378; telecare = 375)
QALY (adjusted meanb) 0.325 (0.312, 0.339) 0.329 (0.313, 0.344) 0.003 (−0.018, 0.024)
Cost (adjusted meanc) 7,610 (6,581, 8,640) 8,625 (7,523, 9,726) 1,014 (−525, 2,553)
ICER (£ per QALY)b,c,d – – 297,000 (undefined, undefined)
Excluding project management costs
Cost (adjusted meanc) 7,605 (6,576, 8,634) 8,522 (7,421, 9,624) 917 (−622, 2,457)
ICER (£ per QALY)b,c,d – – 269,000 (undefined, undefined)
Excluding dedicated response costs
Cost (adjusted meanc) 7,606 (6,577, 8,636) 8,553 (7,451, 9,655) 947 (−593, 2,487)
ICER (£ per QALY)b,c,d – – 277,000 (undefined, undefined)
Sensitivity analyses Total costs/ICER
Equipment prices reduced by 50%
Cost (adjusted meanc) 7,608 (6,579, 8,638) 8,584 (7,483, 9,685) 975 (−563, 2,514)
ICER (£ per QALY)b,c,d – – 286,000 (undefined, undefined)
Mainstream support package of £5 per week
Cost (adjusted meanc) 7,582 (6,550, 8,613) 8,171 (9,278, 7,065) 590 (−955, 2,134)
ICER (£ per QALY)b,c,d – – 173,000 (undefined, undefined)
Equipment prices reduced by 50% and mainstream
support package of £5 per week
Cost (adjusted meanc) 7,580 (6,548, 8,611) 8,131 (7,024, 9,237) 551 (−993, 2,095)
ICER (£ per QALY)b,c,d – – 161,000 (undefined, undefined)
aCases for which baseline costs data were available.
bFrom SUR analyses (outcome equation), adjusted for baseline utility, site, demographic and individual characteristics (age, sex, ethnicity, IMD, number of chronic
conditions, EQ5-D self-care score, previous community alarm, one-person household).
cFrom SUR analyses (cost equation), adjusted for baseline costs, site, demographic and individual characteristics (age, sex, ethnicity, IMD, number of chronic
conditions, EQ5-D self-care score, previous community alarm, one-person household).
dRounded to nearest thousand.
798
C. Henderson et al.
capture entirely the improvements brought by telecare. This
is because it focuses on the individual’s health and restoration
of function rather than achievement of beneﬁt through the
more compensatory mechanisms provided by much of social
care [27] (telecare could be classiﬁed as one such service).
Beneﬁts may accrue primarily to families and carers of tele-
care users rather than telecare users themselves (although
there is little evidence on impact on quality of life, telecare
may reduce carer strain [28]). Any potential beneﬁcial effects
on carers that may have resulted from the introduction of the
telecare intervention have been excluded from the current
analysis. Beneﬁts may particularly accrue to telecare users
with certain characteristics. Willingness to use telecare and
related assistive technologies may be inﬂuenced by concerns
about threats to privacy or to identity [29]. Higher costs may
be associated with telecare users with particular characteris-
tics; the result of closer monitoring may have prompted add-
itional service responses for some people. We plan to explore
these issues in quantitative analyses of trial data, in particular,
the impact of the technology in carers; qualitative evidence
supports important inter-individual differences [cf. 29].
Conclusion
There is great policy interest in the potential of telecare to
improve quality of life while decreasing use and costs of
health and social care support. However, we found that a
package of second-generation telecare equipment and asso-
ciated monitoring service and (in two sites) a dedicated
response service did not constitute a cost-effective alternative
to usual care, assuming a commonly accepted willingness to
pay for QALYs. For the present, given the lack of robust evi-
dence on cost-effectiveness in favour of telecare, policy-
makers should avoid characterising this technology as a
‘magic bullet’ [30].
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